SCHEMBL17832115

SCHEMBL17832115

Cn1c(=O)c(=O)n(N)c2ccc(S(=O)(=O)NC3(C)CC3)cc21

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19770697 0.91 PARG (0.72) PARG
SCHEMBL17832116 0.82 PARG (0.62) PARG
SCHEMBL25404807 0.81 PARG (0.80) PARG
SCHEMBL17824759 0.79 PARG (1.00) PARG
SCHEMBL17824610 0.78 PARG (1.00) PARG
SCHEMBL17824810 0.77 PARG (1.00) PARG
SCHEMBL17824562 0.77 PARG (1.00) PARG
SCHEMBL23644619 0.77 PARG (0.72) PARG
SCHEMBL19770699 0.76 PARG (1.00) PARG
SCHEMBL31121986 0.76 PARG (0.72) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed